- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05434078
Orthofeet: A Prospective Proof of Concept Trial to Evaluate an Innovative Pain Relief Footwear
Orthofeet: A Prospective Proof of Concept Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Pain Relief Footwear
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Baylor College of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 50 years or older
- self reported foot pain including heel, arch, or ball of foot
Exclusion Criteria:
- Plantar ulcer Patients with major foot deformity (e.g., Charcot foot, Pes Cavus)
- Lower extremity amputation including minor amputation. Foot pain because of nail disorder or keratotic lesions (e.g. corns, calluses)
- unstable conditions such as recent stroke, anticipated changes in medication regime
- Acute fractures of the foot
- Non-ambulatory or unable to stand without help or walk a distance of at least 6 feet without assistance.
- major cognitive impairment or major depression
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Orthofeet Shoes
Participants will be given Orthofeet shoes to wear for 6 weeks
|
Participants will wear a pair of Orthofeet shoes to wear for 6 weeks
|
No Intervention: No Orthofeet shoes
This group will not be wearing Orthofeet shoes for 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Foot Pain Intensity
Time Frame: baseline, 1 week, 6 weeks, 7 weeks, 12 weeks
|
Changes in foot pain from baseline to 12 weeks will be assessed by Foot Function Index (FFI) questionnaire.
Score ranges from 0 to 230, the higher the score indicates greater disability/decreased foot function.
|
baseline, 1 week, 6 weeks, 7 weeks, 12 weeks
|
Change in step count from baseline to 6 weeks to 12 weeks
Time Frame: 12 weeks from baseline
|
Step count will be measured over the course of 12 weeks using a smart watch (Vivosmart 4, Garmin, USA)
|
12 weeks from baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Physical Activity
Time Frame: baseline, 6 weeks, and 12 weeks
|
Changes in physical activity from baseline to 12 weeks will be assessed.
Physical activity will be quantified by measuring number of taken steps per day and will be measured using a validated wearable sensor named PAMSys.
Monitoring of physical activity will be done during 48hours at baseline, 6 weeks, and at 12 weeks.
|
baseline, 6 weeks, and 12 weeks
|
Change in Quality of Life
Time Frame: baseline, 6 weeks, and 12 weeks
|
Quality of life will be assessed using a validated questionnaire, called PROMIS Global-10. The PROMIS Global-10 is a 10-item patient-reported questionnaire in which the response options are presented as 5-point (as well as a single 11-point) rating scales. The results of the questions are used to calculate two summary scores: a Global Physical Health Score and a Global Mental Health score. These scores are then standardized to the general population, using the "T-Score". The average "T-Score" for the United States population is 50 points, with a standard deviation of 10 points. Higher scores indicate a healthier patient. |
baseline, 6 weeks, and 12 weeks
|
Change in Gait speed
Time Frame: baseline, 6 weeks, and 12 weeks
|
Change from baseline in Gait speed at 12 weeks.
Gait speed will be measured using a validated wearable platform (LEGSys) during habitual walking speed.
|
baseline, 6 weeks, and 12 weeks
|
Change in Balance
Time Frame: baseline, 6 weeks, and 12 weeks
|
Change in balance from baseline to 12 weeks will be measured.
Balance will be assessed by measuring center of mass sway.
The investigator will use a validated wearable platform (BalanSen) to measure body sway.
|
baseline, 6 weeks, and 12 weeks
|
Change in Fear of Falling
Time Frame: baseline, 6 weeks, and 12 weeks
|
Changes in Fear of falling will be assessed by Short Falls Efficacy Scale International (FES I) questionnaire at 12 weeks and will be compared to baseline measurements.
Scores range from 16 to 64, the higher the score the more concerned the subject is with falling.
|
baseline, 6 weeks, and 12 weeks
|
Change in Cognitive Function
Time Frame: baseline, 6 weeks, and 12 weeks
|
Changes from baseline in cognitive function at 12 weeks.
Cognitive performance will be assessed using Montreal Cognitive Assessment (MoCA).
Scores on the MoCA range from zero to 30, with a score of 26 and higher generally considered normal.
|
baseline, 6 weeks, and 12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Foot Pain
-
Talita Cumi Ltd.Aetrex Worldwide IncCompleted
-
Reuth Rehabilitation HospitalActive, not recruitingChronic Pain of Left Foot (Finding) | Chronic Pain of Right Foot (Finding)Israel
-
Reuth Rehabilitation HospitalActive, not recruitingChronic Pain of Left Foot (Finding) | Chronic Pain of Right Foot (Finding)Israel
-
Noha Khaled ShoukryActive, not recruiting
-
University of PadovaCompletedPlantar Fasciitis | Myofascial Trigger Point Pain | Foot InjuryItaly
-
Cali Pharmaceuticals LLCRecruiting
-
Uppsala UniversityCompletedBack Problems or Pain | Foot Problems or Pain | Shoulder Problems or PainSweden
-
Heron TherapeuticsCompletedPostoperative Pain | BunionsUnited States
-
Dr.med. Sabine SchoenfeldUnknown
-
Karolinska InstitutetWithdrawnPostoperative Pain | Hallux Valgus
Clinical Trials on Orthofeet Shoes
-
Eastern Mediterranean UniversityCompleted
-
University Hospital, BrestCompleted
-
University Hospital, Basel, SwitzerlandCompletedCerebral PalsySwitzerland
-
Assaf-Harofeh Medical CenterUnknownCerebral Palsy | Poststroke/CVA ParesisIsrael
-
University Hospital, GenevaCompleted
-
IRCCS National Neurological Institute "C. Mondino...Not yet recruitingParkinson Disease | Gait Disorders
-
University of LiverpoolLiverpool University Hospitals NHS Foundation TrustCompletedAging | FallsUnited Kingdom
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
University of AarhusAarhus University HospitalCompleted